T1	Participants 93 175	49 patients (22 women, 27 men, mean age 43.7 [21-65] years) with Hodgkin's disease
T2	Participants 220 277	median of 5.37 (2-10) years after the end of chemotherapy
T3	Participants 1180 1211	patients with Hodgkin's disease
